megestrol acetate has been researched along with Marasmus in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Logomarsino, JV; Smith, CS | 1 |
Ghossein, C; Kalantar-Zadeh, K; Liang, A; Rammohan, M | 1 |
Auchus, RJ; Benson, CA; Chesney, MA; Egorin, MJ; Liu, T; Mulligan, K; Sattler, FR; Schambelan, M; Shriver, S; Umbleja, T; Von Roenn, JH; Zackin, R | 1 |
1 review(s) available for megestrol acetate and Marasmus
Article | Year |
---|---|
Using megestrol acetate to ameliorate protein-energy wasting in chronic kidney disease.
Topics: Appetite Stimulants; Humans; Megestrol Acetate; Protein-Energy Malnutrition; Renal Insufficiency, Chronic; Wasting Syndrome | 2016 |
2 trial(s) available for megestrol acetate and Marasmus
Article | Year |
---|---|
Megestrol acetate in a moderate dose for the treatment of malnutrition-inflammation complex in maintenance dialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Anorexia; Anthropometry; Body Composition; Body Mass Index; Body Weight; C-Reactive Protein; Dietary Proteins; Energy Intake; Female; Humans; Hypoalbuminemia; Inflammation; Kidney Failure, Chronic; Leptin; Male; Megestrol Acetate; Middle Aged; Nutritional Status; Prospective Studies; Protein-Energy Malnutrition; Renal Dialysis; Serum Albumin; Syndrome; Treatment Outcome | 2005 |
Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
Topics: Adult; Androgens; Appetite Stimulants; Body Composition; Double-Blind Method; Drug Therapy, Combination; HIV Wasting Syndrome; Humans; Hydrocortisone; Male; Megestrol Acetate; Middle Aged; Placebos; Protein-Energy Malnutrition; Quality of Life; Sexuality; Testosterone; Treatment Outcome; Weight Loss | 2007 |